Yu-Yong Eugene Tai
Adult Medicine · Jasper, ALNPI 1205817947
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.2% of the total across 151 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 18.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $893 and has fallen 91.0% since, to $80 in 2022.
Across 151 payments — averaging $15.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$432
- AbbVie$320
- Johnson & Johnson$237
- Merck$220
- Pfizer$200
- Novo Nordisk$158
- plus $787 from 15 others
What the payments were for
- Food & beverage$2,31098%
- Education$432%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 26 | $432 |
| AbbVie(2 entities) | 31 | $320 |
| Johnson & Johnson | 14 | $237 |
| Merck | 13 | $220 |
| Pfizer | 11 | $200 |
| Novo Nordisk | 10 | $158 |
| GSK | 8 | $148 |
| Lilly USA, LLC | 7 | $114 |
| Amarin Pharma, Inc. | 6 | $88 |
| Esperion Therapeutics, Inc. | 4 | $79 |
| AstraZeneca | 3 | $59 |
| Arbor Pharmaceuticals, Inc. | 2 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $46 |
| UCB, Inc. | 2 | $36 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $28 |
| Kowa Pharmaceuticals America, Inc. | 2 | $27 |
| Evoke Pharma, Inc. | 2 | $26 |
| Dexcom, Inc. | 2 | $24 |
| Mylan Specialty L.p. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $19 |
| Boehringer Ingelheim | 1 | $15 |
How this compares
$2,353 in reported general payments places this provider in the 65th percentile of 26 adult medicine providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Famotidine | 12 | $455 |
| Omeprazole | 12 | $410 |
| Levothyroxine Sodium | 19 | $118 |
| Verapamil Hcl | 12 | $100 |
Paid to pharmacies, not to this prescriber.
Other adult medicine in Jasper
- Eyston HunteMobile$139K
- Delano BenjaminForestdale$10K
- Walter BrandnerBirmingham$9K
- Jeremy LedfordOpelika$9K
- Eric BeckerMobile$7K
- William SargeantMontgomery$6K
- Anthony ChestangBirmingham$5K
- Jeremy AllenPell City$4K
- Adeel BodlaMadison$4K
- Justin CulliferMobile$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.